Resumen de acción HIMS
Hims & Hers Health, Inc. gestiona una plataforma de telesalud que conecta a consumidores con profesionales sanitarios autorizados en Estados Unidos, el Reino Unido e internacionalmente.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Hims & Hers Health, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.26 |
| 52 Week High | US$17.16 |
| 52 Week Low | US$5.65 |
| Beta | 0.91 |
| 1 Month Change | -22.40% |
| 3 Month Change | 31.54% |
| 1 Year Change | -6.48% |
| 3 Year Change | 4.26% |
| 5 Year Change | n/a |
| Change since IPO | 14.90% |
Noticias y actualizaciones recientes
Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing
May 04
Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry
Apr 24Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation
Apr 05Recent updates
Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing
May 04Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry
Apr 24Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation
Apr 05Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock
Mar 21Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health
Mar 12Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%
Feb 28Hims & Hers: Turning The Profitability Corner And Returning 28%
Feb 25Hims & Hers Health: No Clear Moat Besides First Mover Advantage
Jan 23Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple
Jan 10Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)
Jan 07Hims & Hers Health Q3: The Cheapest Growth Stock Around
Dec 14Hims & Hers Health: What Would The Author Of 100 Baggers Say?
Nov 30Hims & Hers: The Most Undervalued Small Cap Stock I See
Nov 08Hims & Hers: A Promising Company With Resolvable Challenges
Nov 02Hims & Hers: Specialization Is The Secret To Great Growth
Oct 25Hims & Hers Health: Can't Get Much Better
Sep 25The Market Is Wrong On Hims & Hers Health
Sep 18Hims & Hers: The Current Weakness Creates A Buying Opportunity
Aug 15Hims & Hers Health: Giving Investors Another Bite At The Apple
Aug 01Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues
Jul 21Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong
Jul 13Hims & Hers Health: Double-Edged Sword
Jul 02Hims & Hers: More Transparency Could Help The Stock
Jun 09Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business
Apr 19Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?
Mar 30Him & Hers Health Q4 2022 Earnings Preview
Feb 24Hims & Hers spikes as Jefferies upgrades ahead of 2023 guidance
Feb 09Hims & Hers: Profitability Pulled Forward
Jan 25Hims & Hers Health: Buy Into The Strong Growth Momentum
Jan 18Devon Energy And Hims & Hers Health - Raul Shah's Hot Take
Jan 05Hims & Hers Health: The Ultimate Pick For 2023
Dec 23Hims & Hers Health: The Unicorn (Former) SPAC For 2023
Dec 17Hims & Hers Health Seems Like A Great Pick For 2023
Dec 10Rentabilidad de los accionistas
| HIMS | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | -9.9% | -1.9% | 0.7% |
| 1Y | -6.5% | -0.1% | 23.9% |
Rentabilidad vs. Industria: Los resultados de HIMS fueron inferiores a los de la industria US Healthcare, que obtuvo un rendimiento del 2.1% el año pasado.
Rentabilidad vs. Mercado: HIMS obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| HIMS volatility | |
|---|---|
| HIMS Average Weekly Movement | 12.0% |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de HIMS ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de HIMS(12%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de US.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| n/a | 1,046 | Andrew Dudum | www.forhims.com |
Hims & Hers Health, Inc. opera una plataforma de telesalud que conecta a los consumidores con profesionales sanitarios autorizados en Estados Unidos, Reino Unido e internacionalmente. La empresa ofrece una gama de productos y servicios de salud y bienestar, con y sin receta, que los clientes pueden adquirir directamente a través de sus sitios web y su aplicación móvil. También suministra medicamentos de venta con receta de forma recurrente y atención continuada por parte de proveedores sanitarios; y productos de venta libre de medicamentos y dispositivos, cosméticos y suplementos centrados principalmente en el bienestar general, la salud y el bienestar sexual, el cuidado de la piel y el cuidado del cabello.
Resumen de fundamentos de Hims & Hers Health, Inc.
| Estadísticas fundamentales de HIMS | |
|---|---|
| Capitalización bursátil | US$2.42b |
| Beneficios(TTM) | -US$23.55m |
| Ingresos (TTM) | US$872.00m |
2.8x
Ratio precio-ventas (PS)-102.6x
Ratio precio-beneficio (PE)¿Está HIMS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de HIMS | |
|---|---|
| Ingresos | US$872.00m |
| Coste de los ingresos | US$157.05m |
| Beneficio bruto | US$714.95m |
| Otros gastos | US$738.50m |
| Beneficios | -US$23.55m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 06, 2024
| Beneficios por acción (BPA) | -0.11 |
| Margen bruto | 81.99% |
| Margen de beneficio neto | -2.70% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado HIMS a largo plazo?
Ver rendimiento histórico y comparativa